What Is Driving Innovation in the Hormone-Refractory Oncology Drug...

טלפון אחר

2026-07-21 05:55:27 -

What Is Driving Innovation in the Hormone-Refractory Oncology Drug Market?

According to the latest report published by Data Bridge Market Research, the Hormone-Refractory Oncology Drug Market CAGR Value The global hormone-refractory oncology drug market size was valued at USD 5.33 billion in 2025 and is expected to reach USD 12.46 billion by 2033, at a CAGR of 11.20% during the forecast period This Hormone-Refractory Oncology Drug Market research...

0 תגובות 0 שיתופים